Litigation Details for Teva Pharmaceuticals USA Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)
✉ Email this page to a colleague
Teva Pharmaceuticals USA Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)
Docket | ⤷ Subscribe | Date Filed | 2014-10-06 |
Court | District Court, D. Delaware | Date Terminated | 2017-01-31 |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Patents | 8,232,250; 8,399,413 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Teva Pharmaceuticals USA Inc. v. Mylan Pharmaceuticals Inc.
Details for Teva Pharmaceuticals USA Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2014-10-06 | 1 | of United States Patent No. 8,232,250 (“the ’250 patent”) and United States Patent No. 8,399,413 (“the…206936. COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 8,232,250 BY DEFENDANTS 72. The allegations…JUDGMENT OF INFRINGMENT OF U.S. PATENT NO. 8,232,250 BY DEFENDANTS 87. The allegations… BACKGROUND The ’250 Patent 50. The ’250 patent, entitled “Low Frequency Glatiramer… the ’250 patent. 53. Teva Ltd. is the exclusive licensee of the ’250 patent. | External link to document | |
2014-10-06 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,232,250 B2; US 8,399,413 …2014 31 January 2017 1:14-cv-01278 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |